Cargando…

Update and Extension of Release Criteria for Canine (117m)Sn Treatments

Tin-117 m ((117m)Sn) is used to treat dogs with osteoarthritic joints by radiosynoviorthesis. The internal conversion and Auger electrons emitted by the (117m)Sn provide the therapeutic effect. Sn-117 m also emits x rays and gamma rays, of which the most significant is 158.6 keV. Accurate informatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Arno, Matthew G., Stevenson, Nigel, Smith, Chad, Donecker, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063182/
https://www.ncbi.nlm.nih.gov/pubmed/36749306
http://dx.doi.org/10.1097/HP.0000000000001680
_version_ 1785017655837589504
author Arno, Matthew G.
Stevenson, Nigel
Smith, Chad
Donecker, John
author_facet Arno, Matthew G.
Stevenson, Nigel
Smith, Chad
Donecker, John
author_sort Arno, Matthew G.
collection PubMed
description Tin-117 m ((117m)Sn) is used to treat dogs with osteoarthritic joints by radiosynoviorthesis. The internal conversion and Auger electrons emitted by the (117m)Sn provide the therapeutic effect. Sn-117 m also emits x rays and gamma rays, of which the most significant is 158.6 keV. Accurate information regarding the interactions of a person with a treated dog is needed to determine the person’s total dose and thus regulatory compliance; i.e., a time and motion study. Prior studies have characterized the radiation field emitted by a treated dog, determined the effective dose rates to a person based on those radiation fields, and evaluated dog-human interactions. These studies have been tied together to calculate the prospective dose to the owner of a treated dog. The behavior modifications needed to comply with public dose limits were identified, and a template for written instructions limiting dose was developed. Further calculations based on the written instructions were made to determine the necessary duration of the instructions. The result is guidance that may be used by veterinary practitioners to release treated dogs in accordance with the public dose limits.
format Online
Article
Text
id pubmed-10063182
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-100631822023-03-31 Update and Extension of Release Criteria for Canine (117m)Sn Treatments Arno, Matthew G. Stevenson, Nigel Smith, Chad Donecker, John Health Phys Papers Tin-117 m ((117m)Sn) is used to treat dogs with osteoarthritic joints by radiosynoviorthesis. The internal conversion and Auger electrons emitted by the (117m)Sn provide the therapeutic effect. Sn-117 m also emits x rays and gamma rays, of which the most significant is 158.6 keV. Accurate information regarding the interactions of a person with a treated dog is needed to determine the person’s total dose and thus regulatory compliance; i.e., a time and motion study. Prior studies have characterized the radiation field emitted by a treated dog, determined the effective dose rates to a person based on those radiation fields, and evaluated dog-human interactions. These studies have been tied together to calculate the prospective dose to the owner of a treated dog. The behavior modifications needed to comply with public dose limits were identified, and a template for written instructions limiting dose was developed. Further calculations based on the written instructions were made to determine the necessary duration of the instructions. The result is guidance that may be used by veterinary practitioners to release treated dogs in accordance with the public dose limits. Lippincott Williams & Wilkins 2023-05 2023-02-06 /pmc/articles/PMC10063182/ /pubmed/36749306 http://dx.doi.org/10.1097/HP.0000000000001680 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Health Physics Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Papers
Arno, Matthew G.
Stevenson, Nigel
Smith, Chad
Donecker, John
Update and Extension of Release Criteria for Canine (117m)Sn Treatments
title Update and Extension of Release Criteria for Canine (117m)Sn Treatments
title_full Update and Extension of Release Criteria for Canine (117m)Sn Treatments
title_fullStr Update and Extension of Release Criteria for Canine (117m)Sn Treatments
title_full_unstemmed Update and Extension of Release Criteria for Canine (117m)Sn Treatments
title_short Update and Extension of Release Criteria for Canine (117m)Sn Treatments
title_sort update and extension of release criteria for canine (117m)sn treatments
topic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063182/
https://www.ncbi.nlm.nih.gov/pubmed/36749306
http://dx.doi.org/10.1097/HP.0000000000001680
work_keys_str_mv AT arnomatthewg updateandextensionofreleasecriteriaforcanine117msntreatments
AT stevensonnigel updateandextensionofreleasecriteriaforcanine117msntreatments
AT smithchad updateandextensionofreleasecriteriaforcanine117msntreatments
AT doneckerjohn updateandextensionofreleasecriteriaforcanine117msntreatments